Cargando…
What we have to know about corticosteroids use during Sars-Cov-2 infection
PURPOSE: Glucocorticoids (GCs), alone or associated to other drugs, were widely used in the management of patients affected by severe acute respiratory syndrome caused by SARS-CoV-2 infection, during the recent COVID-19 outbreak. This review summarizes the available data on HPA axis impairment in GC...
Autores principales: | Ferraù, F., Ceccato, F., Cannavò, S., Scaroni, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454136/ https://www.ncbi.nlm.nih.gov/pubmed/32860209 http://dx.doi.org/10.1007/s40618-020-01384-5 |
Ejemplares similares
-
What we know and what we need to know about the origin of SARS-CoV-2
por: Domingo, Jose L.
Publicado: (2021) -
What we know about ocular manifestations of Ebola
por: Moshirfar, Majid, et al.
Publicado: (2014) -
Asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014) -
Why Do We Need to Know What the Public Thinks about Nanotechnology?
por: Cormick, Craig
Publicado: (2009) -
Erratum: asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)